IL18R1 and Parkinson disease: The ROC curves showed that IL18R1 (AUC:0.913), NMUR1 (AUC:0.838) and RELA (AUC:0.825) all had good diagnostic performance, suggesting that they may be potential therapeutic targets for PD (Fig 6B).